# Srinivas Akkaraju

Srinivas Akkaraju of Palo Alto, CA appears across SEC filings — Form ADV advisers, Form D, Reg A, and crowdfunding offerings. 15 filing roles across Form D (13), Form ADV (1), Form 13F (1).

## Filings (15)

| Filed | Source | Entity | Role | Location |
| --- | --- | --- | --- | --- |
| 2025-03-31 | Form ADV | [SAMSARA BIOCAPITAL, LLC](https://search.stillhousedata.com/firm/288114) | MANAGER OF SAMSARA BIOCAPITAL, LLC | — |
| 2026-08-14 | Form 13F | [SAMSARA BIOCAPITAL, LLC](https://search.stillhousedata.com/firm/288114) | Managing Member | PALO ALTO, CA |
| 2009-06-01 | Form D | [SEATTLE GENETICS INC /WA](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1060736&type=&dateb=&owner=include&count=40) | Director | BOTHELL, WA |
| 2012-11-02 | Form D | [Presidio Pharmaceuticals, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1467435&type=&dateb=&owner=include&count=40) | Director | SAN FRANCISCO, CA |
| 2014-02-20 | Form D | [Aravive, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1513818&type=&dateb=&owner=include&count=40) | Director | HOUSTON, TX |
| 2018-09-05 | Form D | [Principia Biopharma Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1510487&type=&dateb=&owner=include&count=40) | Director | SOUTH SAN FRANCISCO, CA |
| 2022-09-21 | Form D | [LS22, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1556263&type=&dateb=&owner=include&count=40) | Director | CAMBRIDGE, MA |
| 2020-12-31 | Form D | [Samsara BioCapital, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1699737&type=&dateb=&owner=include&count=40) | Director | PALO ALTO, CA |
| 2020-10-21 | Form D | [Chinook Therapeutics U.S., Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1768185&type=&dateb=&owner=include&count=40) | Director | SEATTLE, WA |
| 2019-11-05 | Form D | [565 SPV I, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1734426&type=&dateb=&owner=include&count=40) | Director | PALO ALTO, CA |
| 2023-09-07 | Form D | [Tentarix Biotherapeutics, LP](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1822549&type=&dateb=&owner=include&count=40) | Director | San Diego, CA |
| 2024-03-11 | Form D | [ALUMIS INC.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1847367&type=&dateb=&owner=include&count=40) | Director | SOUTH SAN FRANCISCO, CA |
| 2022-06-13 | Form D | [Mineralys Therapeutics, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1933414&type=&dateb=&owner=include&count=40) | Director | RADNOR, PA |
| 2024-08-28 | Form D | [OrsoBio, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2000354&type=&dateb=&owner=include&count=40) | Director | MENLO PARK, CA |
| 2025-09-26 | Form D | [Samsara Opportunity Fund, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2086193&type=&dateb=&owner=include&count=40) | Director | PALO ALTO, CA |


---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.